Heterozygous Toll-Like Receptor 2 Polymorphism Does Not Affect Lipoteichoic Acid-Induced Chemokine and Inflammatory Responses

Infection and Immunity

Volumn 72, Issue 3, 2004, Pages 1828-1831

  Von Aulock, Sonja ^a   Schröder, Nicolas W J ^b   Traub, Stephanie ^a   Gueinzius, Katja ^a   Lorenz, Eva ^c   Hartung, Thomas ^a   Schumann, Ralf R ^b   Hermann, Corinna ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; TOLL LIKE RECEPTOR 2;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC TRANSFECTION; HETEROZYGOSITY; HUMAN; HUMAN CELL; INFLAMMATION; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

CHEMOKINES; HETEROZYGOTE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10744224022     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.3.1828-1831.2004     Document Type: Article

References (10)

1. Erridge, C., J. Stewart, and I. R. Poxton. 2003. Monocytes heterozygous for the Asp299Gly and Thr399IIe mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 197:1787-1791.
2. Hermann, C., I. Spreitzer, N. W. Schroder, S. Morath, M. D. Lehner, W. Fischer, C. Schutt, R. R. Schumann, and T. Hartung. 2002. Cytokine induction by purified lipoteichoic acids from various bacterial species-role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur. J. Immunol. 32:541-551.
3. Lehner, M. D., S. Morath, K. S. Michelsen, R. R. Schumann, and T. Hartung. 2001. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166:5161-5167.
4. Lien, E., and R. R. Ingalls. 2002. Toll-like receptors. Crit. Care Med. 30:S1-S11.
5. Lorenz, E., J. P. Mira, K. L. Cornish, N. C. Arbour, and D. A. Schwartz. 2000. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68:6398-6401.
6. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193:393-397.
7. Morath, S., A. Geyer, I. Spreitzer, C. Hermann, and T. Hartung. 2002. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 70:938-944.
8. Morath, S., A. Stadelmaier, A. Geyer, R. R. Schmidt, and T. Hartung. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195:1635-1640.
9. Schröder, N. W., C. Hermann, L. Hamann, U. B. Gobel, T. Hartung, and R. R. Schumann. 2003. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. 81:368-372.
10. von Aulock, S., N. W. Schröder, K. Gueinzius, S. Traub, S. Hoffmann, K. Graf, S. Dimmeler, T. Hartung, R. R. Schumann, and C. Hermann. 2003. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J. Infect. Dis. 188:938-943.